{"brief_title": "Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy", "brief_summary": "OBJECTIVES: I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial myopathy.", "detailed_description": "PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day. If patient experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day over 3 months for compassionate use. The patient is followed at weeks 3, 8, and 12.", "condition": ["Mitochondrial Myopathy"], "intervention_type": ["Drug"], "intervention_name": ["thioctic acid"], "criteria": "PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Long standing ophthalmoparesis and fatiguable weakness of the limbs - Mild ataxia and no central nervous system involvement - History of mitochondrial DNA deletion and a measurable biochemical defect of the respiratory chain - Steady deterioration in skeletal muscle mass and power over 5 years --Prior/Concurrent Therapy-- - Previous participation in studies of muscle disease natural history (CRC Protocol 183A)", "gender": "Male", "minimum_age": "N/A", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "rare disease", "mesh_term": ["Muscular Diseases", "Mitochondrial Myopathies", "Thioctic Acid"], "id": "NCT00004770"}